SCREENING METHODOLOGY AND MINIMIZING THE RISK OF OVERDOSE
ENDURING RECORDED COURSE: Registration now open
Time of Enduring Recorded Course: One hour
This is the fifth of six modules in a live webinar and enduring recorded course series on opioid addiction prevention. This module is designed to train and inform New Jersey health care professionals with prescribing authority, as well as nurses and mental health professionals, on screening methodology, naloxone co-prescribing, and harm reduction strategies.
All participants who register for and complete this course will receive access to the New Jersey Opioid Medical Education Program Naloxone Distribution and Training Programs Guide. This comprehensive county-by-county guide, available in interactive and print formats for health care professional reference and patient education, includes pharmacies who dispense NARCAN® (naloxone hydrochloride) Nasal Spray and the recent FDA-approved generic naloxone hydrochloride nasal spray (utilizing standing orders, and via prescription). It also includes virtual trainings in the era of COVID–19 on how and when to use naloxone nasal spray.
Target Audience: Physicians, Physician Assistants, Podiatrists, Certified Nurse Midwives, Advanced Practice Nurses, Registered Nurses, Psychologists, Social Workers, Professional Counselors, Marriage and Family Therapists
Objectives: At the conclusion of this activity, participants will be able to:
- Provide reasoning for early screening, brief intervention, and referral for treatment of patients with opioid use disorder (OUD), with a special focus on pregnant women and adolescents.
- Compare various screening methodologies for predicting aberrant opioid-related behavior among patients receiving opioids for chronic pain management, and those using illicit fentanyl, heroin, and other drugs.
- Recognize chronic pain strategies to minimize or avoid the use of opioids for pain management, with a special focus on opioid dose tapering, and alternative pain therapies including non opioid pharmacotherapy, psychosocial interventions, and osteopathic manipulative treatment (OMT).
- Provide reasoning for increased patient access to mental health professionals for mental health comorbidities, and primary care practitioners and infectious disease specialists for HIV, Hepatitis B (HBV), and Hepatitis C (HCV) testing.
- Understand that harm reduction is a set of policies to reduce the morbidity of substance use including opioids, benzodiazepines, stimulants, and anabolic steroids.
- Identify the significance of harm reduction as a social and health care intervention for individuals who inject substances with a special focus on lifesaving risk mitigation strategies including syringe exchange programs.
- Instruct patients on proper management, storage, and disposal of opioids.
- Recognize the lifesaving importance of naloxone with a special focus on co-prescribing and community training and distribution programs.
AVAILABLE CREDIT FOR PHYSICIANS:
Rowan University School of Osteopathic Medicine (RowanSOM) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians.
RowanSOM designates this program for a maximum of 1 AOA Category 1-B credit and will report CME and specialty credit commensurate with the extent of the physician’s participation in this activity.
Rowan University School of Osteopathic Medicine (RowanSOM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
RowanSOM designates this internet enduring activity for 1 AMA PRA Category 1 credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
To receive a certificate of completion, and CME certificate, complete the Pre-Assessment, Post-Assessment, Knowledge Assessment, Attestation Form, and Outcome Survey/Evaluation.
AVAILABLE CREDIT FOR OTHER LISTED HEALTH CARE PROFESSIONALS: This enduring recorded course satisfies the statutory mandate that physician assistants, podiatrists, advanced practice nurses, certified nurse midwives, registered nurses, psychologists, social workers, professional counselors, and marriage and family therapists obtain one credit in continuing education programs concerning prescription opioid drugs as a condition of licensure renewal. Upon successful completion of the enduring recorded course, participants will receive a certificate of completion, and should retain it in accordance with their relevant licensing board’s regulations.
To receive full credit, you must be present for the entire enduring recorded course activity.
All listed health care professionals must complete the Pre-Assessment, Post Assessment, and Knowledge Assessment to receive a certificate of completion.
All listed health care professionals must complete the Attestation Form, and Outcome Survey/Evaluation. Upon completion of these items, Physicians will receive a CME certificate.
Hearing Impaired Registrants: The enduring recorded course will contain closed captioning.
For questions pertaining to the New Jersey Licensing Boards, and questions and/or feedback pertaining to module content, please contact Patricia Fortunato, RowanSOM NMI Content Manager/Program Manager at firstname.lastname@example.org
For questions pertaining to AOA and ACCME CME credits, please contact Tara Shontz, RowanSOM Program Coordinator at email@example.com
For technical support with registration and access to the module, please contact the Rowan Online Marketplace Center submit an email ticket here.